Results 51 to 60 of about 14,122,838 (258)
First Nations Information Governance Centre Data Online
, 2015 FNIGC Data Online is an online service from the First Nations Information Governance Centre (FNIGC), Canada’s premier source of information about First Nations people living on reserve and in northern communities.
First Nations Information Governance Centre
core
Multiple Sclerosis Relapse Activity After Ozanimod Discontinuation in DAYBREAK Trial Participants
Annals of Clinical and Translational Neurology, EarlyView.Multiple Sclerosis Relapse Activity After Ozanimod Discontinuation in DAYBREAK Trial Participants. ABSTRACT Objective Return of disease activity is expected when patients discontinue disease‐modifying therapy (DMT) for multiple sclerosis (MS). Some MS DMTs are associated with higher‐than‐expected disease activity (rebound) after discontinuation.
Ralf Gold +12 more
wiley +1 more source
Fighting for the Taste Buds of Our Children
Journal of Agriculture, Food Systems, and Community Development, 2019 In this commentary, I focus on the impacts of Indian boarding school food on American Indian foodways and community as a source of acculturation that has a lasting effects even in the present day.
A-dae Romero-Briones
doaj +1 more source
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective To evaluate the efficacy and safety of ofatumumab in patients with myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD), and compare it with rituximab. Methods We conducted a single–center, observational study including 22 MOGAD patients treated with ofatumumab and 21 treated with rituximab.
Yuxin Fan +5 more
wiley +1 more source
Safety and Tolerability of Givinostat: Evidence From Real‐World and Clinical Practice
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective The aim of our study was to establish the prevalence of adverse events in a real‐world setting in boys living with Duchenne muscular dystrophy (DMD) treated with givinostat as part of an Expanded Access Program (EAP) in Italy. Methods The cohort included 90 ambulant boys, with age when treatment started between 6 and 23 years (mean ...
Marika Pane +19 more
wiley +1 more source
First Nations Graduates 2001-2002
, 2002 Shannon Waters, Gilbert Anderson Jr., Jaya Supernant, Kisha Supernant, Jaimee Charlie, Shawn Hunt, Leah Fointain, Donna Koop, Lee Robin Caffrey, Don McIntyre, Graeme Joseph, Jennifer Mackie, Jan Hare, Ursula Schmitt, Wendy Lynn Gaspard, Odelia Dennis ...
core
Comparative Effectiveness and Safety of Inebilizumab Versus Rituximab in AQP4‐IgG‐Positive NMOSD
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective Rituximab (anti‐CD20, RTX) and inebilizumab (anti‐CD19, INE) represent B‐cell‐depleting therapies used for aquaporin‐4 antibody‐positive (AQP4‐IgG+) neuromyelitis optica spectrum disorder (NMOSD); however, direct comparative evidence remains limited.
Jie Lin +11 more
wiley +1 more source
UBC 1997 First Nations Graduates
, 1997 Back Row: Mary McNeill, Stefany Mathias, Lennard Joe, Marietta Einarson, Allyson Anderson, Nadine Caron, Bernice Touchie, Dr. Daniel Birch / Middle Row: Earla Calahaisn, Kika Mowry, Mar-y-paz Rivera, Francesa Vinson, Peter Nyce, JoAnne Moiese-Bob ...
core
MOGAD Is the Most Common Cause of Isolated Optic Neuritis in Children
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objectives The study aimed to characterize the clinical features, etiologies, and outcomes of isolated, first‐time pediatric ON in the post‐MOG‐IgG era. Methods This was a single‐center retrospective cohort study at Texas Children's Hospital of patients diagnosed with first‐time ON between 2018–2024, with follow‐up data collected through 2025.
Chaitanya Aduru +13 more
wiley +1 more source